GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
RRBGX
Price
$170.09
Change
-$4.26 (-2.44%)
Updated
Feb 21 closing price
Net Assets
64.04B
Ad is loading...

GFACX vs RRBGX

Header iconGFACX vs RRBGX Comparison
Open Charts GFACX vs RRBGXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
T. Rowe Price Blue Chip Growth R
Price$170.09
Change-$4.26 (-2.44%)
VolumeN/A
Net Assets64.04B
GFACX vs RRBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RRBGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RRBGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. RRBGX (64B). GFACX (0.00) and RRBGX (0.00) have matching dividends . GFACX was incepted earlier than RRBGX: GFACX (24 years) vs RRBGX (22 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. RRBGX (9.80). GFACX has a lower initial minimum investment than RRBGX: GFACX (250) vs RRBGX (2500). RRBGX annual gain was more profitable for investors over the last year : 11.93 vs. GFACX (10.15). RRBGX return over 5 years is better than : 35.83 vs. GFACX (32.83).
GFACXRRBGXGFACX / RRBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD2.9801.298230%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets304B64B475%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.1511.9385%
Returns for 3 years17.6925.4270%
Returns for 5 years32.8335.8392%
Returns for 10 years55.63146.1138%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding